Onxeo SA (EUR)
ONXEO
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range0.70 | 0.72
52-Wk Range- | -
Last Close0.70
Mkt Cap (m)54.74
Dividend yield-
ISINFR0010095596
Volume52,077.00
Exchange VenuePAR

Company Profile

Onxeo SA is engaged in the development of drugs for the treatment of orphan diseases in particular in oncology. Its pipeline products include AsiDNA 1V, AsiDNA+chemo/radio, AsiDNA+Belinostat/HDACi and others.

Key Information
Price/Earning-
Price/Book3.18
Price/Sales9.98
P/CF-
Rev Growth (3 year avg)-1.04
EPS Growth (3 year avg)-
Operating Margin % -368.38
Net Margin %-786.57
Return on Equity-107.76
Debt/Equity0.50

Documents

Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

http://www.onxeo.com

Financials

Income Statement
EUR201420152016201720182019
Revenue (m)22.083.484.429.516.134.29
Operating Income (m)-0.62-22.17-23.17-66.38-15.64-15.80
Net Income (m)-7.70-19.41-22.67-59.07-9.40-33.73
Basic EPS-0.19-0.48-0.48-1.17-0.18-0.55
Avg. Diluted Shares Outstanding (m)40.5440.5447.0450.7053.3860.98
Balance Sheet
EUR201420152016201720182019
Current Assets (m)62.9541.7036.8730.8620.3811.28
Non Current Assets (m)89.0587.5488.2347.2242.8726.35
Total Assets (m)152.00129.24125.1078.0763.2537.63
Current Liabilities (m)12.9210.6112.4218.848.396.20
Total Liabilities (m)------
Total Equity (m)121.97102.8094.0949.8745.4017.20
Cash Flows
EUR201420152016201720182019
Operating Cash Flows (m)-7.72-23.12-17.61-28.28-11.27-7.70
Capital Expenditure (m)0.00-0.25-0.55-0.07-0.05-0.03
Figures are quoted in EUR unless stated otherwise
-
No change
0.70
Last Price